Vaccine

THE main challenge to raising production of Covid-19 vaccines is how to quickly and effectively transfer technology, Germany’s health minister said on Friday, reiterating Berlin’s opposition to a US proposal to waive patent protection.

“The main issue is not patent protection but production capacity,” Jens Spahn told a news conference.

Taking a jab at the US goverment’s decision, Spahn also said: “I would be delighted if the United States shows the same willingness to export vaccines that we in Germany do.”